Gene · 708
NIH grants1,264
NIH grants whose papers are about the gene, through NIH's grant-paper links.
561 to 580 of 1,264
Download this page as JSON| Grant | Title | C1QBP papers | Newest fiscal year |
|---|---|---|---|
| RF1AG062661 | VGF peptide TLQP-21, a novel microglial C3aR1 modulator in Alzheimer's disease | 1 | 2019 |
| RF1DA048811 | New approaches for single cell tagging, editing and profiling of glial cells in vivo | 1 | 2019 |
| T32GM007040 | Predoctoral Training in Pharmacological Sciences | 1 | 2019 |
| T32GM007205 | Medical Scientist Training Program | 1 | 2019 |
| T32GM007223 | Predoctoral Program in Cellular and Molecular Biology | 1 | 2019 |
| T32GM007240 | Cell and Molecular Genetics Training Program | 1 | 2019 |
| T32GM008367 | TRAINING PROGRAM IN BIOCHEMISTRY, CELL AND DEVELOPMENT BIOLOGY | 1 | 2019 |
| T32GM008715 | Biotechnology Training Grant | 1 | 2019 |
| T32GM108556 | Cellular Engineering Biotechnology Training Program | 1 | 2019 |
| U01HG008701 | The Electronic Medical Records and Genomics (eMERGE) Network Phase III - Coordinating Center (U01) | 1 | 2019 |
| U01HL131914 | Channelopathies and Cardiomyopathies Among Sudden Deaths in the Young | 1 | 2019 |
| U24CA194107 | GenePattern Notebooks for Cancer Research | 1 | 2019 |
| U54NS091859 | Modifiers of FMR1-associated Disorders: Application of High Throughput Technologi | 1 | 2019 |
| UG3EB025765 | Multi-tissue platform for modeling systemic pathologies | 1 | 2019 |
| P01AI068730 | Complement in inflammatory diseases: mechanisms & therapeutic modulation | 7 | 2018 |
| R56AI122376 | gC1qR as a therapeutic target for angioedema. | 5 | 2018 |
| R01CA188883 | A nanosystem for tumor treatment and imaging | 4 | 2018 |
| R01DE015254 | P. gingivalis as a keystone pathogen | 4 | 2018 |
| K01AR065506 | Regulation of LAIR-1 in Lupus | 3 | 2018 |
| P01AG000538 | Behavioral and Neural Plasticity in the Aged | 3 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/708/grants?page=29